1-3 of 3
Alan F. Wahl, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Humanized Anti-CD40 Monoclonal Antibody SGN-40 Targets Hodgkin’s Disease Cells through Multiple Mechanisms.

Che-Leung Law, PhD, Julie A. McEarchern, PhD, Charles G. Cerveny, MS, Leia M. Smith, PhD, Albina Nesterova, MS, Kristine A. Gordon, BS, Iqbal S. Grewal, PhD, Alan F. Wahl, PhD
Journal: Blood
Blood (2005) 106 (11): 1476.
https://doi.org/10.1182/blood.V106.11.1476.1476
Published: 2005
Journal Articles

A Humanized Anti-CD70 Monoclonal Antibody Targets CD70-Expressing Multiple Myeloma.

Julie A. McEarchern, PhD, Charlotte McDonagh, PhD, Allen Ho, BA, Yu-Tzu Tai, PhD, Leigh Francisco, BS, Kerry Klussman, BS, Carol Morris-Tilden, BS, Kristine Gordon, BS, Ezogelin Oflazoglu, PhD, Kim Kissler, Nikhil Munshi, MD, Kenneth C. Anderson, MD, Steven P. Treon, MD, PhD, Paul Carter, PhD, Alan F. Wahl, PhD, Iqbal S. Grewal, PhD, Che-Leung Law, PhD
Journal: Blood
Blood (2005) 106 (11): 1591.
https://doi.org/10.1182/blood.V106.11.1591.1591
Published: 2005
Journal Articles

The Anti-CD30 Monoclonal Antibody SGN-30 Inhibits Hodgkins Disease Growth and Sensitizes Cells to Established Chemotherapeutics.

Charles G. Cerveny, MS, Che-Leung Law, PhD, Renee S. McCormick, BS, Joel S. Lenox, MS, Kevin J. Hamblett, PhD, Lori E. Westendorf, BS, Andrew K. Yamane, BS, Joseph M. Petroziello, MS, Joseph A. Francisco, PhD, Alan F. Wahl, PhD
Journal: Blood
Blood (2004) 104 (11): 2639.
https://doi.org/10.1182/blood.V104.11.2639.2639
Published: 2004